Identification of monoclonal nonspecific suppressor factor beta (MNSF beta) as one of the genes differentially expressed at implantation sites compared to interimplantation sites in the mouse uterus
Gy. Nie et al., Identification of monoclonal nonspecific suppressor factor beta (MNSF beta) as one of the genes differentially expressed at implantation sites compared to interimplantation sites in the mouse uterus, MOL REPROD, 55(4), 2000, pp. 351-363
Successful implantation requires synchronous development of and active dial
ogue between the maternal endometrium and the implanting blastocyst. While
it is well established that appropriate maternal steroid hormones are essen
tial for endometrial preparation for implantation, the molecular events at
the actual site of implantation are still little understood. The aims of ou
r studies were to identify genes explicitly expressed or repressed at the s
ites of implantation by utilising RNA differential display (DDPCR), and to
establish the roles of these genes in the implantation process in a mouse m
odel. Ten bands unique in implantation sites compared to interimplantation
sites were identified by DDPCR and subsequently confirmed by Northern blott
ing. One of these bands contained a cDNA fragment that was highly homologou
s to mouse monoclonal nonspecific suppressor factor beta (MNSF beta) or Fau
. The full cDNA sequence of this gene, obtained by screening a lambda gt11
cDNA library, was essentially the same as MNSF beta, except that it had muc
h longer 5' untranslated region. Interestingly, both Northern and immunohis
tochemical analysis showed that the expression of this gene was much lower
in implantation sites compared to interimplantation sites on day 4.5 of pre
gnancy, when embryos first attach to the uterus and initiate implantation,
and on day 5.5, when implantation has advanced. These results suggest a rol
e for MNSF during implantation and early pregnancy, possibly through regula
ting the proliferation and/or differentiation of uterine stromal cells. It
may also be involved in the selective production of TH2-type cytokines in i
mplantation sites to regulate the immune system at the maternal-fetal inter
face. Mol. Reprod. Dev. 55:351-363, 2000. (C) 2000 Wiley-Liss, Inc.